Ragosa Mark sold KNSA
January 8, 2026 · Form 4 insider transaction
Ragosa Mark sold 12,000 shares of Kiniksa Pharmaceuticals International, plc at $41.89 per share, a transaction worth $502.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
12,000
Price
$41.89
Total value
$502.7K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateJanuary 8, 2026
Filing dateJanuary 9, 2026
Shares owned after19,086
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on August 14, 2025.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $41.44 and $42.24. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.